Cargando…

Changes in glutamatergic neurotransmission within the migraine cycle

Detalles Bibliográficos
Autores principales:	Cosentino, G, Paladino, P, Fierro, B, Brighina, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619999/ http://dx.doi.org/10.1186/1129-2377-14-S1-P126

Ejemplares similares

EHMTI-0280. Cortical excitability changes in chronic migraine vs episodic migraine: evidence by sound-induced flash illusions
por: Brighina, F, et al.
Publicado: (2014)

O069. Menstrual cycle affects cortical excitability differently in females with migraine and in healthy controls: a new perspective by cross modal sound induced flash illusions
por: Maccora, Simona, et al.
Publicado: (2015)

P072. The visual cortical excitability in pediatric migraine as tested by sound-induced flash illusions
por: Di Marco, Salvatore, et al.
Publicado: (2015)

Is lack of habituation a biomarker of migraine? A critical perspective
por: Brighina, Filippo, et al.
Publicado: (2015)

Targeted sensors for glutamatergic neurotransmission
por: Hao, Yuchen, et al.
Publicado: (2023)

Effects of Psychotherapy on Glutamatergic Neurotransmission
por: Wade-Bohleber, Laura, et al.
Publicado: (2023)

Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
por: Bartolini, M, et al.
Publicado: (2013)

Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
por: Montanari, Martina, et al.
Publicado: (2022)

Orexinergic neurotransmission in temperature responses to amphetamines
por: Molkov, Yaroslav I, et al.
Publicado: (2013)

O046. Color vision and visual cortex excitability are impaired in episodic migraine. Simply coexisting or pathophysiologically related dysfunctions?
por: Brighina, Filippo, et al.
Publicado: (2015)

TMS-EEG signatures of glutamatergic neurotransmission in human cortex
por: Belardinelli, Paolo, et al.
Publicado: (2021)

Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea
por: Kaczmarski, Piotr, et al.
Publicado: (2023)

Intracortical facilitation within the migraine motor cortex depends on the stimulation intensity. A paired-pulse TMS study
por: Cosentino, Giuseppe, et al.
Publicado: (2018)

EHMTI-0220. Cortical excitability in episodic cluster headache
por: Cosentino, G, et al.
Publicado: (2014)

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior
por: Basu, Alo C., et al.
Publicado: (2008)

Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission
por: Scoriels, L, et al.
Publicado: (2015)

Impact of the glutamatergic neurotransmission within the A5 region on the cardiorespiratory response evoked from the midbrain dlPAG
por: González-García, M., et al.
Publicado: (2022)

Computational Investigation of the Changing Patterns of Subtype Specific NMDA Receptor Activation during Physiological Glutamatergic Neurotransmission
por: Singh, Pallab, et al.
Publicado: (2011)

Microglial Morphology and Dynamic Behavior Is Regulated by Ionotropic Glutamatergic and GABAergic Neurotransmission
por: Fontainhas, Aurora M., et al.
Publicado: (2011)

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
por: Kadriu, Bashkim, et al.
Publicado: (2018)

Ketamine attenuates the glutamatergic neurotransmission in the ventral posteromedial nucleus slices of rats
por: Fu, Bao, et al.
Publicado: (2017)

The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020)

Sensory Input-Dependent Changes in Glutamatergic Neurotransmission- Related Genes and Proteins in the Adult Rat Trigeminal Ganglion
por: Fernández-Montoya, Julia, et al.
Publicado: (2016)

The borderline between cluster headache and migraine: does cluster-migraine exist?
por: Lisotto, C, et al.
Publicado: (2013)

Evaluation of vestibular evoked myogenic potentials in migraine and migrainous vertigo patients
por: ÇatýkerÜtkür, B, et al.
Publicado: (2013)

S7. INVESTIGATING THE LINK BETWEEN THE PERIPHERAL ENDOCANNABINOID SYSTEM AND CENTRAL GLUTAMATERGIC NEUROTRANSMISSION IN EARLY PSYCHOSIS: A 7T-MRS STUDY
por: Minichino, Amedeo, et al.
Publicado: (2020)

A case of atypical sporadic hemiplegic migraine associated with PFO and hypoplasia of vertebro-basilar system
por: Brighina, Filippo, et al.
Publicado: (2009)

The comorbidity between migraine and hypothyroidism
por: Lisotto, C, et al.
Publicado: (2013)

Eletriptan provides consistent migraine relief: results of a within-patient multiple-dose study
por: Almas, M, et al.
Publicado: (2013)

Key role of the dopamine D(4) receptor in the modulation of corticostriatal glutamatergic neurotransmission
por: Bonaventura, Jordi, et al.
Publicado: (2017)

Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?
por: Khlghatyan, Jivan, et al.
Publicado: (2018)

A role for primary cilia in glutamatergic synaptic integration of adult-born neurons
por: Kumamoto, N, et al.
Publicado: (2012)

Cortical inhibition and habituation to evoked potentials: relevance for pathophysiology of migraine
por: Brighina, Filippo, et al.
Publicado: (2009)

Multimodal evoked potentials in chronic migraine
por: Coppola, G, et al.
Publicado: (2013)

The Biology of the Glutamatergic System and Potential Role in Migraine
por: Gasparini, C. F., et al.
Publicado: (2013)

Survey of the differences between Migraine and MOH pre-existing migraine
por: Igarashi, H
Publicado: (2013)

Estrogenic-dependent glutamatergic neurotransmission from kisspeptin neurons governs feeding circuits in females
por: Qiu, Jian, et al.
Publicado: (2018)

An intellectual-disability-associated mutation of the transcriptional regulator NACC1 impairs glutamatergic neurotransmission
por: Daniel, James A., et al.
Publicado: (2023)

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
por: Aurora, SK, et al.
Publicado: (2013)

The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
por: Silberstein, S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lcou297fqjp1cf3oeq5t0mjbdo